Exercise on the Mitigation of Anthracycline-Associated Cardiotoxic Effects in Pediatric Cancer Survivors: A Review

Exercise on the Mitigation of Anthracycline-Associated Cardiotoxic Effects in Pediatric Cancer Survivors: A Review

Bibliographic Details
Main Author:	Vazquez, Danny Alberto, Jr.
Other Authors:	Keen, Douglas
Language:	en
Published:	The University of Arizona. 2013
Online Access:	http://hdl.handle.net/10150/311812

Similar Items

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Review on the pathophysiology of anthracycline-induced cardiotoxicity
by: Tiago Alexandre de Oliveira Valente
Published: (2019)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

In vitro evaluation of anthracycline-induced cardiotoxicity and mitigation by perturbation of angiotensin signalling
by: Rockley, Kimberly Louise
Published: (2018)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

The genetics of anthracycline-induced cardiotoxicity in cancer patients
by: Naidoo, Horacia
Published: (2018)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
by: Marwa Tantawy, et al.
Published: (2021-01-01)

The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01)

Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018-11-01)

Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
by: Benedict T. Costello, MBBS, PhD, et al.
Published: (2019-12-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Assessing cardiotoxicity in randomised trials of anthracycline in cancer patients
by: Kerr, Amanda J.
Published: (2015)

Cardiotoxicity in anthracycline therapy: Prevention strategies
by: Margarida Cruz, et al.
Published: (2016-06-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

About the article “Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients”
by: Elia de la Caridad Rodríguez-Venegas, et al.
Published: (2020-04-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Detection of anthracycline induced cardiotoxicity by cardiac biomarkers
Published: (2020-11-01)

Anthracycline-induced cardiotoxicity : the role of proteolytic pathways
by: Sishi, Balindiwe J. N. (Balindiwe Jennifer Nonkosazana)
Published: (2012)

Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
by: Vivian Wing-yi Li, et al.
Published: (2018-12-01)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020-05-01)

Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
by: Wei Hao MD, et al.
Published: (2020-07-01)

microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
by: Jéssica Diniz Pereira, et al.
Published: (2020-11-01)

Diagnosis, Prevention, Treatment and Surveillance of Anthracycline-Induced Cardiovascular Toxicity in Pediatric Cancer Survivors
by: Valerie Curren, et al.
Published: (2021-01-01)

Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
by: Hugh Montgomery, et al.
Published: (2009-01-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
by: Verrill Mark, et al.
Published: (2010-06-01)

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials
by: Lesley, A. Smith, et al.
Published: (2010)

Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
by: Siew Lian Leong, et al.
Published: (2017-02-01)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dd71ti8a4ghircmtj8gbpdebva